Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117729935 | 11772993 | 5 | F | 20160809 | 20151124 | 20160816 | EXP | PHHY2015BR152835 | NOVARTIS | 0.00 | F | Y | 60.00000 | KG | 20160816 | OT | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117729935 | 11772993 | 1 | PS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 5 MG, Q12MO | 21817 | 5 | MG | SOLUTION FOR INJECTION | |||||||
| 117729935 | 11772993 | 2 | SS | ACLASTA | ZOLEDRONIC ACID | 1 | Unknown | UNK | 21817 | SOLUTION FOR INJECTION | |||||||||
| 117729935 | 11772993 | 3 | C | NEOVIT | 2 | Unknown | UNK | U | 0 | ||||||||||
| 117729935 | 11772993 | 4 | C | CALCIUM | CALCIUM | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 117729935 | 11772993 | 5 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | UNK | U | 0 | |||||||||
| 117729935 | 11772993 | 6 | C | REMERON | MIRTAZAPINE | 1 | Unknown | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 117729935 | 11772993 | 7 | C | REMERON | MIRTAZAPINE | 1 | UNK | 0 | TABLET | ||||||||||
| 117729935 | 11772993 | 8 | C | ABLOK | ATENOLOL | 1 | Unknown | 50 MG, QD | U | 0 | 50 | MG | TABLET | QD | |||||
| 117729935 | 11772993 | 9 | C | EXODOS | 2 | Unknown | 45 MG, UNK | U | 0 | 45 | MG | ||||||||
| 117729935 | 11772993 | 10 | C | RIVOTRIL | CLONAZEPAM | 1 | Oral | 7 DROPS PER NIGHT, | U | 0 | 7 | GTT | DROP |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117729935 | 11772993 | 1 | Osteoporosis |
| 117729935 | 11772993 | 3 | Product used for unknown indication |
| 117729935 | 11772993 | 4 | Mineral supplementation |
| 117729935 | 11772993 | 5 | Product used for unknown indication |
| 117729935 | 11772993 | 6 | Panic disorder |
| 117729935 | 11772993 | 8 | Hypertension |
| 117729935 | 11772993 | 9 | Panic disorder |
| 117729935 | 11772993 | 10 | Panic disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117729935 | 11772993 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117729935 | 11772993 | Abdominal discomfort | |
| 117729935 | 11772993 | Angiopathy | |
| 117729935 | 11772993 | Balance disorder | |
| 117729935 | 11772993 | Blindness | |
| 117729935 | 11772993 | Bone pain | |
| 117729935 | 11772993 | Cataract | |
| 117729935 | 11772993 | Concomitant disease aggravated | |
| 117729935 | 11772993 | Erythema | |
| 117729935 | 11772993 | Fall | |
| 117729935 | 11772993 | Gastritis | |
| 117729935 | 11772993 | Lens disorder | |
| 117729935 | 11772993 | Malaise | |
| 117729935 | 11772993 | Melanocytic naevus | |
| 117729935 | 11772993 | Neoplasm malignant | |
| 117729935 | 11772993 | Neoplasm skin | |
| 117729935 | 11772993 | Pain in extremity | |
| 117729935 | 11772993 | Pallor | |
| 117729935 | 11772993 | Peripheral swelling | |
| 117729935 | 11772993 | Rib fracture | |
| 117729935 | 11772993 | Skin atrophy | |
| 117729935 | 11772993 | Skin papilloma | |
| 117729935 | 11772993 | Upper limb fracture | |
| 117729935 | 11772993 | Varicose vein |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117729935 | 11772993 | 1 | 20140701 | 0 | ||
| 117729935 | 11772993 | 2 | 20150808 | 0 |